Arginase Activity in Patients with Breast Cancer: An Analysis of Plasma, Tumors, and Its Relationship with the Presence of the Estrogen Receptor

Publisher： Karger

E-ISSN： 2296-5262|35|10|570-574

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.35, Iss.10, 2012-09, pp. : 570-574

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Preoperative Neutrophil/Lymphocyte Ratio Does not Correlate with the 21-Gene Recurrence Score in Estrogen Receptor-Positive Breast Cancer Patients

By  

Oncology Research and Treatment, Vol. 38, Iss. 1-2, 2015-01 ,pp. : 24-27

Karger

Access to resources Recommend Favorite

Scattered Fat Invasion: An Indicator for Poor Prognosis in Premenopausal, and for Positive Estrogen Receptor in Postmenopausal Breast Cancer Patients

By  

Oncology, Vol. 59, Iss. 1, 2000-11 ,pp. : 25-30

Karger

Access to resources Recommend Favorite

Which Patients with Estrogen Receptor-Positive Early Breast Cancer Should Be Treated with Adjuvant Chemotherapy?

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 18-22

Karger

Access to resources Recommend Favorite

Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients

By  

Molecular Oncology, Vol. 12, Iss. 1, 2018-01 ,pp. : 48-57

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of Estrogen Receptor Beta and Phosphorylation of Estrogen Receptor Alpha Serine 167 Correlate with Progression-Free Survival in Patients with Metastatic Breast Cancer Treated with Aromatase Inhibitors

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 55-61

Karger

Access to resources Recommend Favorite